Cutaneous vasculitis is a condition characterized by inflammation of the blood vessels in the skin. It can present as a localized rash or as a systemic illness. The cause of the condition is not always known, and the diagnosis and treatment of cutaneous vasculitis can be challenging. This guide provides an overview of the diagnosis and treatment of cutaneous vasculitis, including the types of tests used to diagnose the condition, the medications used to treat it, and the lifestyle modifications that can help manage symptoms.
Cutaneous vasculitis can be divided into two main categories: primary and secondary. Primary cutaneous vasculitis is a condition that is not associated with an underlying disease or disorder. Examples of primary cutaneous vasculitis include Henoch-Schonlein purpura, urticarial vasculitis, and hypersensitivity vasculitis. Secondary cutaneous vasculitis is caused by an underlying medical condition, such as an infection, autoimmune disorder, or malignancy. Examples of secondary cutaneous vasculitis include lupus erythematosus, rheumatoid arthritis, and inflammatory bowel disease.
The diagnosis of cutaneous vasculitis is based on a combination of clinical history, physical examination, laboratory tests, and imaging studies. A thorough medical history should be taken to identify any associated conditions or medications that may be contributing to the symptoms. The physical examination should focus on the skin, looking for signs of inflammation, such as redness, swelling, or ulceration. Laboratory tests are used to evaluate the function of the immune system and to look for signs of an infection or autoimmune disorder. These tests may include complete blood count (CBC), erythrocyte sedimentation rate (ESR), C-reactive protein (CRP), rheumatoid factor (RF), antinuclear antibodies (ANA), and antineutrophil cytoplasmic antibodies (ANCA). Imaging studies, such as X-rays, ultrasound, or MRI, may also be used to evaluate the extent of the condition and to look for any associated conditions.
The treatment of cutaneous vasculitis is tailored to the individual and depends on the underlying cause. If the cause is an infection, then antibiotics may be prescribed. If the cause is an autoimmune disorder, then immunosuppressive medications may be prescribed. Nonsteroidal anti-inflammatory drugs (NSAIDs) may be used to reduce inflammation and pain. Corticosteroids may be used to reduce inflammation, but they should be used with caution as they can have serious side effects. In addition to medications, lifestyle modifications can help manage symptoms. These may include avoiding triggers, such as certain foods or medications, and avoiding activities that can aggravate the condition. Keeping the skin moisturized, wearing loose-fitting clothing, and avoiding excessive sun exposure can also help.
Cutaneous vasculitis is a condition characterized by inflammation of the blood vessels in the skin. The diagnosis and treatment of cutaneous vasculitis can be challenging, as the cause is not always known. Diagnosis is based on a combination of clinical history, physical examination, laboratory tests, and imaging studies. Treatment is tailored to the individual and may include medications, such as antibiotics or immunosuppressants, and lifestyle modifications, such as avoiding triggers and keeping the skin moisturized. With the right diagnosis and treatment, the symptoms of cutaneous vasculitis can be managed and the condition can be kept under control.
1.
A single-cell analysis reveals a distinctive immunosuppressive tumor microenvironment in kidney cancer brain metastases.
2.
The FDA approves Enhertu for HER2-positive cancers, regardless of tumor type.
3.
Cancer diagnosis does not spur improvements to survivors' diets or eating habits
4.
According to a study by Amrita Hospital in Kochi, cancer mortality is rising among Indian women while declining for men.
5.
A garden can save your life
1.
Reshaping the Battlefield Through Tumor Microenvironment Modulation for Cancer Therapy
2.
Understanding Epoetin and Its Role in Treating Chronic Kidney Disease
3.
Biologic Therapies for Cutaneous Immune-Related Adverse Events in the Era of Immune Checkpoint Inhibitors
4.
Cracking the Code of Subdural Hematomas: Modern Strategies for Optimal Care
5.
Imaging in Peritoneal Neoplasms: Diagnostic Advances and Multimodal Treatment Strategies
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
A Panel Discussion on Clinical Trial End Point for Tumor With PPS > 12 months
2.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part V
3.
An In-Depth Look At The Signs And Symptoms Of Lymphoma- Further Discussion
4.
Incidence of Lung Cancer- An Overview to Understand ALK Rearranged NSCLC
5.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part III
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation